EXEL EXELIXIS, INC.

NEUTRAL Impact: 3/10 DEFA14A
Horizon days Filed Apr 17, 2026 Processed 1mo ago SEC 0001628280-26-025746
Proxy solicitation materials
Latest settled — T+20d
EXEL ▲ +14.32% at T+20d
NEUTRAL call ✓ call won +14.32% · α vs SPY +10.11% · entry $43.59 → $49.83
Next anchor: T+60d in 5w
Currently $52.99 · +21.57% from $43.59 entry
Entry anchored
Apr 17, 03:59 PM ET
via Databento tick
T+1d
+5.25%
call +5.25% · α +5.91%
$45.88
settled 7w ago
T+5d
+2.13%
call +2.13% · α +1.22%
$44.52
settled 7w ago
T+20d
+14.32%
call +14.32% · α +10.11%
$49.83
settled 26d ago
T+60d
call — · α —
in 5w

Price Chart

Loading chart...

Executive Summary

Exelixis, Inc. filed a supplement to its definitive proxy statement to clarify the voting standard for Proposal No. 3, which relates to the approval of the Amended 2017 Plan. The clarification specifies that a majority of shares present or represented by proxy is required for approval, with abstentions counting as votes against and broker non-votes having no effect.

Actionable Insight

Investors should note the voting implications for Proposal No. 3, particularly that abstentions will negatively impact passage. However, no material change to corporate strategy, governance, or financials is indicated.

Key Facts

  • The filing is a supplement to the DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders.
  • The sole purpose is to correct the voting standard description for Proposal No. 3 (Amended 2017 Plan).
  • The required vote is a majority of shares present or represented by proxy; abstentions count as votes against, broker non-votes have no effect.
  • No other changes are made to the original proxy statement.

Financial Impact

No direct financial impact; this is a procedural clarification.

Risk Factors

  • If shareholder support is close, the clarified voting standard could affect the outcome of Proposal No. 3 due to the treatment of abstentions.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001628280-26-025746
Document: 0001628280-26-025746-index-headers.html0001628280-26-025746
Document: 0001628280-26-025746-index.html0001628280-26-025746
Document: 0001628280-26-025746.txt0001628280-26-025746
10 reports for EXEL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EXEL — sortable, filterable
Type Now
Jun 3, 2026
6d ago
Insider Cluster
NEUTRAL ★ 2/10
$52.39 $52.69▲ +0.57%▲ +3.17%$52.99 (+1.15%)
May 29, 2026
11d ago
8-K
NEUTRAL ★ 3/10
$50.20 $48.49▼ −3.41%▼ −3.55%$52.99 (+5.56%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.28▼ −0.08%▼ −0.35%$52.99 (+5.31%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.28▼ −0.08%▼ −0.35%$52.99 (+5.31%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.20▼ −0.24%▼ −0.50%$52.99 (+5.31%)
May 22, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$49.94 $49.82▼ −0.24%▼ −0.25%$52.99 (+6.11%)
May 19, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$49.89 $49.49▼ −0.80%▼ −1.00%$52.99 (+6.22%)
May 7, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$46.10 $48.15▲ +4.45%▲ +3.62%$52.99 (+14.95%)
Apr 17, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$43.59 $45.88▲ +5.25%▲ +5.91%$52.99 (+21.57%)
Feb 28, 2026
14w ago
Institutional Cluster
BULLISH ★ 7/10
$40.98 $40.58▼ −0.98%▼ −0.06%$52.99 (+29.31%)
Showing 10 of 10

US Market Status

Market Closed — Opens Thu (9h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access